Add Yahoo as a preferred source to see more of our stories on Google. Like most variations of dementia, LBD is a complex neurodegenerative disorder, and the exact causes are not yet completely ...
What is dementia with Lewy bodies? Dementia is caused by different diseases that affect the brain. Lewy body dementia is caused by Lewy body disease. In this disease, tiny clumps of proteins known as ...
Please provide your email address to receive an email when new articles are posted on . The introduction of additional neflamapimod in an open-label extension led to significant clinical improvements.
Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds. The phase II trial was small, ...
Prostate medications might help reduce the risk of a specific type of dementia, a new study suggests. People were less likely to develop Lewy body dementia when taking drugs designed to treat urinary ...
Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in Alzheimer's & Dementia. Although DLB is the second most common ...
MIAMI, Fla. (Ivanhoe Newswire) - We all know about Alzheimer’s disease, in fact, many of us know someone who has been impacted by it. But there is another form of dementia that affects more than a ...
New research suggests a possible link between depression and serious brain disorders.
"Every day there’s new grief," says a caretaker in PEOPLE's exclusive clip from the documentary 'Facing the Wind' The heartbreaking toll of dementia is explored in a new documentary, Facing the Wind, ...
Mark Stewart talks ahead of a new ultrasound trial in Oxford to help prevent Lewy Body Dementia.
Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB), according to a new study. The researchers think that a specific side effect of ...
Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer's disease and Parkinson's disease but studies on long-term treatments are lacking. A new study from Karolinska ...